 (longitudinal: -12.1 ± 5.4% vs. -15.9 ± 1.96%, p < 0.0001; radial: 34.4 ± 15.3% vs. 47.2 ± 11.4%, p < 0.0001; circumferential: -16.8 ± 4.3% vs. - (longitudinal strain: -11.2 ± 5.4% vs. -12.3 ± 5.4%, p = 0.52; longitudinal strain rate: -0.73 ± ± 0.23%/s vs. 0.80 ± 0.35%/s, p = 0.53; radial strain: 29.5 ± 19.6% vs. 35.2 ± 14.5%, p = 0.24 (Cardiol J 2018; 25, 2: 203-212) 
Introduction
Aortic stenosis (AS) is the most common valvular pathology in western populations, especially in the elderly [1] . Indication for aortic valve replacement in patients with severe AS is given as soon as typical symptoms occur [2] . In patients at intermediate to high surgical risk, transcatheter aortic valve replacement (TAVR) has been shown to be superior to surgical valve replacement [3] [4] [5] .
Several factors such as need for hemodynamic support during procedure, extent of paravalvular leakage, chronic kidney or pulmonary disease have been identified to influence early and midterm prognosis after TAVR [6, 7] . However most studies forming the evidence base concentrate on acute outcomes. Hence there is little data on outcomes beyond the first year of follow-up [8, 9] . Valid prognostic information is of special interest as it might provide important contributions to risk stratification and clinical decision making especially in the context of present ongoing randomized trials in patients with a low risk for surgical valve replacement.
Cardiac magnetic resonance imaging (CMR) plays an increasing role in the diagnostic management of patients suffering from valvular pathologies [10] . In addition to its favorable advantages like high spatial and temporal resolution, lack of ionizing radiation and excellent reproducibility, it is considered the gold standard for the evaluation and quantification of left and right ventricular functional parameters such as volumes and ejection fractions [11] . Consequently, CMR has proven to provide important prognostic information in various valvular and non-valvular cardiac diseases [12] [13] [14] . Most recently, new parameters for the quantification of left ventricular mechanics and function have been introduced to CMR. The assessment of global and regional strain and subsequent parameters such as strain rate, displacement and velocity by feature tracking (FT) CMR is thought to have the potential to improve the quantification of cardiac function and thus might lead to an improvement of CMR's prognostic value [15] [16] [17] [18] [19] .
The objective of this study was to make an assessment of standard functional and innovative deformation parameters in patients after TAVR by CMR and the evaluation of their prognostic impact.
Methods

Study population
Patients with symptomatic severe AS undergoing TAVR were enrolled between 2014 and 2015. Indication for valve replacement was given according to current guidelines [20] . All patients were considered eligible unless they exhibited predefined exclusion criteria such as cardiac or respiratory instability, metal implants or devices unsuitable for CMR, concomitant limiting disease, allergy against gadolinium based contrast agents or severely impaired renal function. Age and sex were matched with a healthy control population and was derived from a database formed within another project which was conducted for establishment of reference values. For these subjects, any form of relevant valvular or coronary artery disease, hypertrophic or dilative cardiomyopathy, diastolic dysfunction or inflammatory heart disease were ruled out.
The study was approved by the institutional ethics committee (clinicaltrials.gov: NCT02162069). Written informed consent was obtained from every patient as well as from healthy controls.
CMR examination
All patients received CMR examination at 3 months after TAVR. CMR imaging was performed on a 1.5 T whole-body clinical magnetic resonance scanner (Achieva 1.5T, Philips Medical Systems, Best, Netherlands) using a 32-channel phased-array receiver coil. CMR examinations were carried out in concordance with current guidelines [21, 22] . A steady-state free precession sequence (SSFP, repetition time 3.4 ms, echo time 1.7 ms, voxel size 1.6 × 1.6 mm, flip-angle a 55°, slice thickness 8 mm, acquisition in end-expiratory breath-hold, 32 cardiac phases) were used for functional imaging of the left and right ventricle in long and short axis orientation. CMR examinations and FT analyzes were performed identically for AS patients and healthy controls.
CMR analysis
Two experienced readers performed offline image analysis in a consensus approach. Epi-and endocardial contours were drawn manually in the long-and short-axis oriented SSFP-images. , leftventricular mass divided by left-ventricular enddiastolic volume) and strain parameters (strain, systolic strain rate, displacement, systolic velocity) were derived from the SSFP cine images using the dedicated software cvi 42® (Version 5.2, Circle Cardiovascular Imaging, Calgary, Canada). Strain parameters in longitudinal and radial orientation were assessed globally and on a segmental basis for the left ventricle according to current recommendations [23] . Global circumferential function was derived from a mid-ventricular slice and expressed as positive number in case of a clockwise rotation (seen from the apex) or as a negative number in case of a counterclockwise movement (example depicted in Figure 1 ).
Research Consortium-2 (VARC-2) criteria. The composite endpoint death of any cause, non-fatal myocardial infarction, hospitalization due to heart failure and cerebral ischemia (not associated to index procedure, after hospital discharge) [24] was analyzed. Non-fatal myocardial infarction was defined according to the current universal definition [25] .
Statistical analysis
To test the correlation between two categorical classification factors, the c 2 test was applied. Continuous variables were tested for normal distribution by the D'Agostino-Pearson test. Variables with normal distribution were reported as mean ± standard deviation and a two-tailed t-test (for independent samples) was used for comparison. Variables without normal distribution were reported as median with percentiles and compared by the Mann-Whitney-U rank sum test. Univariate regression analyses using Cox's proportional hazard models were performed to estimate the predictive value of the variables. Hazard ratio (HR) and corresponding 95% confidence interval (CI) are provided. A p-value < 0.05 was considered significant. Statistical analyses were performed using commercially available software (Stata 13, College Station, USA, MedCalc, Mariakerke, Belgium).
Results
Study population and functional characteristics before TAVR
Eighty-three patients after TAVR for treatment of symptomatic severe AS were enrolled into the study. Mean age was 79.3 ± 5.6 years. Forty-three patients were men (51.8%). Most of the patients presented in functional New York Heart Association (NYHA) class III or IV (n = 72, www.cardiologyjournal.org 86.8%). Mean EuroSCORE II was 5.0 ± 3.6% [26] , Society of Thoracic Surgeons (STS) score for mortality was 5.5 ± 3.7% [27] . Table 1 depicts clinical baseline characteristics including relevant pre-existing conditions and functional characteristics before TAVR in more detail.
Mean LVEF was 57.6 ± 15.7% before TAVR in echocardiography. Ten patients exhibited a LVEF < 35% (12.0%) and 43 (51.8%) patients had pulmonary hypertension. More than moderate mitral and tricuspid valve regurgitation was found in 18 (22.5%) and 13 (16.4%) cases, respectively.
CMR assessment of basic functional and left ventricular deformation parameters
Three months after TAVR, LVEF as assessed by CMR was a mean 61.1 ± 14.0%. A severely impaired LVEF (LVEF < 35%) was present in 5 (6.0%) patients. In comparison to the control group with a mean LVEF of 68.4 ± 5.4%, the LVEF in the TAVR population was significantly lower (p = 0.002). LVEDVI was significantly higher in the TAVR cohort (78.9 ± 23.2 mL/m 2 vs. 65.2 ± ± 16.5 mL/m 2 , p = 0.001) as well as LVMVI (0.86 ± 0.28 g/mL vs. 0.70 ± 0.08 g/mL, p = 0.001). Right ventricular parameters did not statistically differ as detailed in Table 2 . Deformation analysis by FT CMR yielded significantly reduced results in all three orientations for strain (longitudinal: -12.1 ± 5.4% vs. -15.9 ± ± 1.96%, p < 0.0001; radial: 34.4 ± 15.3% vs. 47.2 ± ± 11.4%, p < 0.0001; circumferential: -16.8 ± 4.3% vs. -21.1 ± 2.5%, p < 0.0001). In addition the strain rate in the TAVR population was significantly reduced compared to the control group (longitudinal: -0.79 ± 0.33%/s vs. -0.91 ± 0.23%/s, p = 0.043; radial: 2.5 ± 1.2%/s vs. 2.9 ± 0.9%, p = 0.067; circumferential: -1.1 ± 0.6%/s vs. -1.3 ± 0.3%/s, p = 0.006). Global peak displacement and global peak velocity in radial orientation were also significantly reduced in the TAVR population compared with the control population (displacement: 5.1 ± ± 2.0 mm vs. 6.8 ± 0.87 mm, p < 0.0001; velocity: 33.1 ± 11.9 mm/s vs. 40.7 ± 8.6 mm/s, p < 0.001). In addition, direction of global circumferential strain (clockwise vs. counterclockwise) significantly differed between the TAVR cohort and the control group (2.9 ± 5.2 deg vs. -0.5 ± 5.4 deg).
Follow-up
Median follow-up was 614 days with 61 (73.5%) patients having 12 months follow-up. Thirty-five (42.2%) patients had a follow-up period of more than 2 years. During the follow-up period, 13 endpoints occurred. Five (6.0%) patients died. Two patients had non-fatal myocardial infarctions (2.4%) and 3 (3.6%) patients had to be hospitalized because of heart failure. Cerebral ischemia occurred in 2 (2.4%) subjects. Cumulative event rate was 10.7%. Table 3 depicts characteristics of patients with vs. without event. There is no significant difference with regard to basic clinical features such as age, sex, diabetes or hypertension. Established risk prediction parameters (NYHA class at 3 months follow-up, frailty, STS score and EuroSCORE II) also showed comparable results for both groups. The frequency of cardiac and non-cardiac comorbidities (presence of coronary artery disease, chronic obstructive lung disease, pulmonary hypertension, severe mitral or tricuspid valve regurgitation, paravalvular leakage > 1) was also not significantly different. Patients with event exhibited poorer left and right ventricular functional parameters without reaching statistical significance (LVEF: 57.3 ± ± 11.4% vs. 61.7 ± 14.4%, p = 0.32; LVEDVI: , p = 0.46; LVMVI: 0.83 ± 0.3 g/mL vs. 0.86 ± 0.3 g/mL, p = 0.75; RVEF: 56.9 ± 10.8% vs. 62.6 ± 12.7%, p = 0.15; RVEDVI: 74.6 ± 24.8 mL/m 2 vs. 68.8 ± ± 15.7 mL/m 2 , p = 0.28). Peak strain and peak strain rate in longitudinal and radial orientation tended to be reduced, mid-ventricular circumferential strain did not differ (longitudinal strain: -11.2 ± ± 5.4% vs. -12.3 ± 5.4%, p = 0.52; longitudinal strain rate: -0.73 ± 0.23%/s vs. 0.80 ± 0.35%/s, p = 0.53; radial strain: 29.5 ± 19.6% vs. 35.2 ± ± 14.5%, p = 0.24; radial strain rate: 2.2 ± 1.6%/s vs. 2.6 ± 1.2%/s, p = 0.31). Table 4 compares patients after TAVR without endpoint and healthy controls. Global peak strain was reduced in all orientations (longitudinal: -12.3 ± 5.4% vs. -15.9 ± 2.0, p < 0.0001; radial: 35.2 ± 14.5% vs. 47.2 ± 11.4%, p < 0.0001; mid-ventricular circumferential: -16.8 ± 4.5% vs. -21.1 ± 2.5%, p < 0.0001).
Predictors of outcomes
In Table 5 , analyses of univariate predictors of endpoints are shown. NYHA functional class 3 months after TAVR was the only parameter with significant correlation to event-free survival. Patients persisting in NYHA class III or IV exhibited a HR of 6.69 (p = 0.02). Clinical features, risk prediction models, comorbidities and CMR parameters were not significantly associated with the occurrence of endpoints.
Discussion
The present study evaluates cardiac deformation characteristics of patients 3 months after TAVR and analyzes their correlation to event-free survival in a 2 year follow-up. The main finding is that left-ventricular deformation parameters (strain, strain rate, displacement and velocity) in longitudinal, radial and circumferential orientation were significantly reduced 3 months after successful TAVR in comparison to a healthy control group. This was also true for patients with preserved ejection fraction. Patients with endpoint tended to exhibit lower strain values in comparison to patients without event, though statistical significance was not reached. Despite having higher values by www.cardiologyjournal.org trend, deformation characteristics of AS patients without event still were significantly reduced in comparison to normal controls.
Strain imaging is an emerging technique for the non-invasive evaluation of global and regional left ventricular function [28] . Thus far, most studies addressing this topic are derived from two-dimensional speckle-tracking echocardiography. There are various studies proving prognostic significance of particular speckle-tracking derived strain parameters, foremost being global longitudinal strain. This parameter has proven to be significantly correlated to adverse events in several settings, from heart transplant patients to severe AS [29, 30] . Though this technique is highly accepted and widely available, it exhibits several inherent limitations such as poor inter-reader reproducibility and need for an appropriate 'acoustic window' [31, 32] . FT CMR offers the possibility to derive deformation parameters from standard cine sequences and thus combines the advantages of both imaging modalities [15, 16] . CMR derived left-ventricular strain was an independent predictor of survival in patients with dilated cardiomyopathy [33] . Moreover, it proved to provide significant prognostic power concerning the occurrence of major adverse cardiac events in an all-comers CMR population [34] .
The findings of the present study are in concordance with an earlier study using speckle tracking echocardiography for the assessment of cardiac mechanics in AS patients before and after surgical valve replacement [35] . Patients in this study exhibited significantly lower values for longitudinal (-14.6 ± 4.1% vs. -20.3 ± 2.3%, p < 0.001), radial (33.1 ± 14.8% vs. 38.9 ± 6.4%, p < 0.001) and circumferential strain (-15.2 ± 5.0% vs. -19.5 ± 2.9%, p < 0.001) before TAVR in comparison to normal controls, despite normal LVEF (60 ± 12%). It could be demonstrated that valve replacement lead to an improvement in cardiac function (longitudinal strain: from -14.6 ± 4.1% to -16.4 ± 4.5%, p < 0.001; radial strain: from 33.1 ± ± 14.8% to 37.2 ± 13.4%, p = 0.02; circumferential strain: from -15.2 ± 5.0% to -18.0 ± 5.3%, p < 0.001) but that deformation parameters still were reduced in comparison to healthy controls, especially in longitudinal direction (-16.9 ± 4.8% vs. -20.3 ± 2.3%, p < 0.0001).
A recent study proved the strong correlation between CMR derived deformation parameters and Values are mean ± standard deviation; LVEDVI -left ventricular end-diastolic volume index; LVEF -left ventricular ejection fraction; LVMVI -left ventricular mass/volume index; RVEDVI -right ventricular end-diastolic volume index; RVEF -right ventricular ejection fraction the underlying hemodynamic AS subtype [36] . As it could be demonstrated that positive response after TAVR could be predicted by analysis of longitudinal strain and velocity, it has been suggested that the evaluation of cardiac mechanics could be useful for the right timing of valve replacement. Nevertheless, prognostic implication of persisting subtle functional abnormalities after TAVR remain poorly investigated and are thus unclear [37] . A correlation of deformation parameters to outcomes have not as yet been reported. Many studies report that early events in the first few weeks after TAVR are mainly related to the procedure itself including major vascular complications, bleeding complications, cerebral infarction or severe paravalvular aortic insufficiency [6, 9] . Our cohort consisted of patients with a follow-up CMR 3 months after successful aortic valve replacement. Therefore, early events within the first few weeks after TAVR were excluded from analyses. Though this approach might introduce a certain selection bias, it could be appropriate for the proper identification of predictors of mid-and long-term outcomes after interventional valve replacement. Hence, patients surviving 3 months after TAVR had an excellent prognosis and exhibited only relatively low event rates.
Several observational and register studies sought to identify factors predicting outcomes in patients after TAVR [9, 38, 39] . It is of note that most of these studies reported non-cardiac morbidities being causative for deaths and rehospitalizations during follow-up > 30 days after valve replacement. Interestingly, in all of the studies addressing this issue, left ventricular functional parameters such as LVEF and LVEDVI did not have statistical impact on outcomes after valve replacement, indicating that non-cardiac conditions gain influence after successful treatment of AS. In concordance to this assumption, a strong correlation of NYHA functional class after TAVR and the occurrence of endpoints could be observed in the present study.
Nevertheless, since indication for TAVR is constantly expanding toward patients at low to intermediate risk, it can be assumed that functional cardiac parameters will show greater prognostic power in this population exhibiting lower frequencies of severe comorbidities [40] . Several studies have suggested that the evaluation of deformation characteristics might provide beneficial additive information over the assessment of basic functional parameters alone [15, 16] .
In the present study, a significant association of deformation parameters and poor outcome could not be proven. However, patients with endpoint had lower strain values by trend than patients without endpoint. It can be assumed that the investigated parameters will gain significance in larger AS cohorts and longer follow-up periods, particularly in low-risk AS populations. Thus, evaluation of deformation and mechanical characteristics by CMR seem to be a promising approach to improve understanding of cardiac functional properties and the prognostic implications linked to them. Limitations of the study In this study, patients with severe AS were compared to healthy controls. Since AS is promoted by well-known risk factors like arterial hypertension and hyperlipoproteinemia that also might cause other cardiac morbidities (e.g. coronary artery disease), it is difficult to control for confounding systemic or cardiac conditions that might influence cardiac deformation parameters independently from an existing severe AS.
There is no consensus to date on how to assess and report strain parameters. Therefore, values reported in this study are to a large extent modality and software specific. Comparability between different vendors, imaging modalities and post-processing software needs to be further evaluated and proven.
Conclusions
Assessment of left ventricular deformation parameters by CMR revealed subtle functional abnormalities in comparison to healthy controls. Prognostic significance remains to be further investigated.
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